ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1082

Cancer Risk in Patients with Ankylosing Spondylitis: A Nationwide Population-based Dynamic Cohort Study from Korea

Eunyoung Lee1, Kyung-Do Han 2, Yeong-Wook Song 3 and Eun Young Lee 1, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Seoul, Republic of Korea, 2Department of Biostatistics, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Seoul, Republic of Korea, 3Seoul National University Hospital, Seoul, Republic of Korea

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Ankylosing spondylitis (AS), cancer and malignancy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Epidemiology & Public Health Poster II: Spondyloarthritis & Connective Tissue Disease

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The aim of this study is to determine the risk of overall malignancy and site-specific cancer in ankylosing spondylitis (AS) patients compared with patients without AS in Korea.

Methods: The study utilized the National Health Information Database managed by National Health Insurance Service in Korea. The data from national health screening programs, data related to medical care institutions and a registry of cancer and rare/severe intractable diseases were also included. Patients diagnosed as AS (International Classification of Diseases, 10th revision codes M45.0 and code V140 used in Korea for severe intractable diseases) between 2010 and 2015 were extracted. Of these, patients with a history of cancer during the washout period from 2008 to 2009 were excluded. For the control cohort, an age- and sex-matched population without AS was randomly extracted at a control-to-case ratio of 3:1. The incidence rates for overall and specific cancers were calculated per 1000 person-years. Multivariate Cox regression model was used to evaluate the risk for malignancies. Results presented as hazard ratios (HRs) with 95% confidence intervals (CIs).

Results: A total of 15,979 patients with AS and 47,937 matched controls were included for analysis. The prevalence of diabetes mellitus, hypertension and dyslipidemia which are well known risk factors for cancer were statistically high in AS patients (5.76% vs 4.84%, 16.66% vs 12.34%, 11.3% vs 7.99%, respectively) [ p < 0.0001, p< 0.001 and p < 0.0001. respectively]). Cancer was diagnosed in 311 patients (1.95%) and 931 patients (1.94%) in the AS group and age- and sex-matched control group, respectively. After adjusting age, sex, diabetes mellitus, hypertension, dyslipidemia, regions and income status, patients with AS showed higher risk for lymphoma (HR, 3.052; 95% CI, 1.446-6.446), leukemia (HR, 2.322; 95% CI, 0.911-5.914) and multiple myeloma (HR 2.829; 95% CI, 1.16-6.901). The risk of solid cancers was not different between the two groups.

Conclusion: In this nationwide population-based study in Korea, AS patients were associated with increased risk of hematologic malignancies. Further research is needed to determine the relationship between AS and these malignancies.


ACR figure.docx


Disclosure: E. Lee, None; K. Han, None; Y. Song, Astellas Pharma, Inc., 9; E. Lee, None.

To cite this abstract in AMA style:

Lee E, Han K, Song Y, Lee E. Cancer Risk in Patients with Ankylosing Spondylitis: A Nationwide Population-based Dynamic Cohort Study from Korea [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/cancer-risk-in-patients-with-ankylosing-spondylitis-a-nationwide-population-based-dynamic-cohort-study-from-korea/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cancer-risk-in-patients-with-ankylosing-spondylitis-a-nationwide-population-based-dynamic-cohort-study-from-korea/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology